MKSI changes
Pick any two versions below to diff them.
- Price
- $184.52
- Discount category
- Below intrinsic value
- Intrinsic value source
- AI estimate
- Next earnings
- Feb 4, 2027
- Next earnings is estimate
- Yes
- Company name
- added: MKS
- Sector
- added: Semiconductor equipment and electronics process technology
- About
- added: MKS Inc. (MKSI) is based in Andover, Massachusetts. It supplies instruments, subsystems, lasers, process control systems and specialty chemistry that companies use to make semiconductors, printed circuit boards and advanced packages, and products for specialty industrial uses. It bought Atotech Limited, a plating chemistry company, in August 2022. In the first nine months of 2026, revenue was $3,739 million: the Semiconductor market gave 44%, Electronics & Packaging 30% and Specialty Industrial 26%. In 2025, revenue was $3,931 million. The common stock trades on the Nasdaq in US dollars. MKS files 10-K and 10-Q reports.
- Thesis
- added: The price of MKS depends on how long the current growth of chip equipment and advanced packaging spending lasts, and on the debt from its purchase of Atotech in 2022. In Q3 2026, revenue rose 43% to $1,413 million, Semiconductor revenue rose 54%, and adjusted EBITDA reached a record $434 million. The market pays a moderate multiple because the sales of MKS follow the cycles of semiconductor equipment spending, and earnings can fall fast in a downturn. For the price to rise toward the AI estimate, three things must be true. Revenue and margins must stay near the Q4 2026 guidance of $1,490 million of revenue and $461 million of adjusted EBITDA through 2027. MKS must keep reducing debt and close the $650 million sale of Ophir Optics. Demand from AI chips and advanced packaging must offset weaker industrial markets. The Q4 2026 report, expected in early February 2027, is the next test, and the results of 2027 show if the cycle holds.
- Valuation
- added: The intrinsic value for MKS is an AI estimate from November 14, 2026. It is not an analyst's value. An AI research agent calculated it from the filings of MKS Inc. with the SEC. The method is a multiple of 2027 adjusted EBITDA, less net debt, divided by the shares, the restricted stock units and the net shares from the convertible notes. The Form 10-K for 2025 gives 2025 net revenues of $3,931 million. The Q3 2026 release (8-K, November 4, 2026) gives Q3 revenue of $1,413 million, up 43%, GAAP net income of $236 million and adjusted EBITDA of $434 million, and adjusted EBITDA of $1,069 million for nine months. It guides Q4 2026 revenue of $1,490 million, plus or minus $40 million, and adjusted EBITDA of $461 million, plus or minus $29 million, so 2026 adjusted EBITDA is about $1,530 million. The Form 10-Q for the quarter ended September 30, 2026 gives term loan principal of $1,315 million, convertible notes of $1,400 million, senior notes of 1,000 million euros carried at $1,134 million, and cash of $676 million, so net debt is $3,173 million. It gives 0.8 million restricted stock units and a conversion price of about $154.27 for the convertible notes, and MKS pays cash for the principal of a conversion. The estimate adds the shares for the conversion value above the principal and leaves out the capped calls that MKS bought, which is an assumption. The cover of the 10-Q gives 67,620,475 shares at October 27, 2026. On October 17, 2026, MKS agreed to sell its Ophir Optics business to TTM Technologies, Inc. for $650 million in cash, and the estimate assumes that the sale does not change the value, which is an assumption. The 2027 adjusted EBITDA and the multiples are assumptions. The low case assumes $1,400 million, because chip equipment spending falls, at 9 times. It gives $137.78 per share. The base case assumes $1,800 million, near the rate of the Q4 2026 guidance, at 12 times, with about 3.6 million more shares from the convertible notes. It gives $255.85 per share. The high case assumes $2,100 million, from more spending on advanced packaging and AI chips, at 14 times. It gives $356.50 per share. The estimate assumes weights of 25%, 50% and 25%. The weighted intrinsic value is $251.50 per share. MKS sells instruments, subsystems, lasers and plating chemistry that chip and circuit board makers qualify into their production processes, which gives switching costs, but its sales follow the cycles of equipment spending, and large suppliers compete with it. As of Nov 14, 2026.
- Risks
- added: The Semiconductor market gave 44% of revenue in the first nine months of 2026. When chip makers cut equipment spending, the revenue and margins of MKS can fall fast. Debt principal was about $3.8 billion at September 30, 2026: term loans of $1,315 million, convertible notes of $1,400 million and senior notes of 1,000 million euros, against cash of $676 million. The term loans have floating rates, with an average of 4.99%. Holders can convert the convertible notes in Q4 2026 at a conversion price of about $154.27. MKS pays the principal in cash and the rest in cash or shares, so conversions use cash or add shares. U.S. import tariffs, actions of other countries against them and export controls on chip equipment can reduce sales to some customers or raise costs. The sale of Ophir Optics must meet closing conditions, and MKS must separate the business from the rest of the company.
- Balance sheet
- added: Cash: $676M Debt: $3.8B Net debt: $3.2B Undrawn credit line: $1.0B Debt due within 12 months: $1.4B Last debt due: 2034 At September 30, 2026, MKS had cash and cash equivalents of $676 million. Debt principal was $1,315 million of secured term loans, $1,400 million of 1.25% convertible senior notes due June 1, 2030, and 1,000 million euros of 4.250% senior notes due February 15, 2034, carried at $1,134 million. The convertible notes were short-term debt because holders could convert them in Q4 2026. The weighted average rate of the term loans was 4.99%. MKS had no borrowings under its revolving credit facility, with up to $1.0 billion available subject to leverage ratio requirements. In November 2026, it prepaid $100 million of the USD term loan. Total stockholders' equity was $3,286 million. As of Sep 30, 2026.
- Checkpoints
- added: Feb 4, 2027 (estimate): Q4 2026 results. Pending. Watch: Revenue is in the guided range of $1,450 million to $1,530 million and adjusted EBITDA is in the range of $432 million to $490 million, and this passes; results below the ranges fail. Q1 2027 (estimate): Close of the Ophir Optics sale. Pending. Watch: MKS closes the $650 million sale to TTM Technologies and uses the cash to reduce debt, and this passes; a failed sale fails.
- Recent events
- added: Nov 4, 2026: MKS reported Q3 2026 results. Revenue rose 43% to a record $1,413 million, GAAP net income was $236 million, or $3.26 per diluted share, and adjusted EBITDA was $434 million. It guided Q4 2026 revenue of $1,490 million, plus or minus $40 million. The Board approved a $500 million share repurchase program and a quarterly dividend of $0.25 per share, and MKS prepaid $100 million of its USD term loan in November. Oct 17, 2026: MKS agreed to sell its Ophir Optics business, which makes infrared thermal imaging and laser optics, to TTM Technologies, Inc. for $650 million in cash. MKS keeps the Ophir brand and the Ophir Instruments business. Aug 5, 2026: MKS reported Q2 2026 results with revenue of $1,248 million, GAAP net income of $175 million and adjusted EBITDA of $358 million. Feb 4, 2026: MKS sold 1.0 billion euros of 4.250% senior notes due 2034 and, with cash on hand, prepaid about $1.3 billion of its USD term loan. Jan 21, 2026: MKS raised its Q4 2025 guidance to revenue of about $1,030 million and adjusted EBITDA of about $248 million, because demand rose in all markets.